- Home
- Report, Assignment, Case Study and Term Paper
- Portfolio Construction And Management (Last Part)
Portfolio Construction And Management (Last Part)
- By Super Admin
- Published 22 August 2008
- Report, Assignment, Case Study and Term Paper
- Unrated
Portfolio Construction And Management
Initial Investment = Tk 40,00,000
We construct portfolios which includes-
•25% equity investment & hold securities.
•25% equity investment& buy or sell securities
•12.5% equity investment & hold securities and 12.5% investment in FDR @10%
•50% equity investment & buy or sell securities and 12.5% investment in FDR @10%
Portfolio A
|
June |
Share Price | ||||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
July |
August |
September |
October |
|
ACI Limited |
200000 |
80.7 |
2478 |
68.4 |
75.1 |
74 |
72 |
|
Beximco Pharmaceuticals |
200000 |
89.3 |
2240 |
70.8 |
75.8 |
74.2 |
70.9 |
|
Bangla Process |
200000 |
130 |
1538 |
135 |
135 |
130.75 |
140 |
|
Imam Button |
200000 |
68.5 |
2920 |
54.75 |
54.25 |
55 |
51.25 |
|
Square Pharmaceuticals |
200000 |
3679.5 |
54 |
3187.75 |
2853.5 |
2802.25 |
2616 |
|
Total Value of equity investment |
1000000 |
868901 |
877075 |
893631 |
914442 | ||
In 'portfolio A' we invest 25% in equity securities of five pharmaceutical companies. We invest equal amount in each company and hold the securities till October and we saw that portfolio value decreased from its initial investment.
Portfolio B
|
July | |||||
|
Company |
Amount to be invested |
Share Price (Beginning) |
Share Purchase |
Share Price (Closing) |
MV at the end of month |
|
ACI Limited |
200000 |
80.7 |
2478 |
80 |
198265.18 |
|
Beximco Pharmaceuticals |
200000 |
89.3 |
2240 |
70.8 |
158566.63 |
|
Bangla Process |
200000 |
130 |
1538 |
135 |
207692.31 |
|
Imam Button |
200000 |
68.5 |
2920 |
54.75 |
159854.01 |
|
Square Pharmaceuticals |
200000 |
3679.5 |
54 |
3680 |
200027.18 |
|
Total Value of equity investment |
924405.31 | ||||
|
August | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Share Price (Closing) |
MV at the end of month |
|
Kohinoor Chemicals |
184881 |
625 |
296 |
644 |
190501.45 |
|
Beximco Pharmaceuticals |
184881 |
70.8 |
2611 |
76 |
198459.90 |
|
Bangla Process |
184881 |
135 |
1369 |
140 |
191728.51 |
|
Imam Button |
184881 |
54.75 |
3377 |
66.25 |
223714.53 |
|
Square Pharmaceuticals |
184881 |
3680 |
50 |
3369 |
169256.60 |
|
Total Value of equity investment |
973660.98 | ||||
|
September | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Share Price (Closing) |
MV at the end of month |
|
Kohinoor Chemicals |
194732 |
644 |
302 |
644 |
194732.20 |
|
Pharma Aids |
194732 |
294 |
662 |
410 |
271565.31 |
|
Bangla Process |
194732 |
140 |
1391 |
140 |
194732.20 |
|
Imam Button |
194732 |
66.25 |
2939 |
64 |
188118.65 |
|
Square Pharmaceuticals |
194732 |
3369 |
58 |
3225 |
186408.83 |
|
Total Value of equity investment |
1035557.18 | ||||
|
October | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Share Price (Closing) |
MV at the end of month |
|
Kohinoor Chemicals |
207111 |
644 |
322 |
665 |
213865.07 |
|
Pharma Aids |
207111 |
410 |
505 |
463.25 |
234010.66 |
|
Bangla Process |
207111 |
140 |
1479 |
145 |
214508.27 |
|
Imam Button |
207111 |
64 |
3236 |
55 |
177986.39 |
|
Glaxo SmithKline |
207111 |
170.2 |
1217 |
178.4 |
217089.78 |
|
Total Value of equity investment |
1057460.17 | ||||
In 'portfolio B' we invest 25% in equity securities of five pharmaceutical companies. We invest equal amount in each company and follow the strategy of buy and sell. We sell the securities that had decreasing price trend and buy securities that had increasing price trend. We saw that portfolio value slightly increased from its initial investment.
Portfolio C
|
June |
July |
August |
September |
October | |||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Share Price |
Share Price |
Share Price |
Share Price |
|
ACI Limited |
100000 |
80.7 |
1239 |
68.4 |
75.1 |
74 |
72 |
|
Beximco Pharmaceuticals |
100000 |
89.3 |
1120 |
70.8 |
75.8 |
74.2 |
70.9 |
|
Bangla Process |
100000 |
130 |
769 |
135 |
135 |
130.75 |
140 |
|
Imam Button |
100000 |
68.5 |
1460 |
54.75 |
54.25 |
55 |
51.25 |
|
Square Pharmaceuticals |
100000 |
3679.5 |
27 |
3187.75 |
2853.5 |
2802.25 |
2616 |
|
Total Value of equity investment |
500000 |
434450 |
438537.67 |
431816 |
422221 | ||
|
Investment in FDR | |
|
Amount |
500000 |
|
Rate |
0.14 |
|
June |
July |
August |
September |
October | |
|
Value of FDR Investment |
505867.5 |
511803.8 |
517809.9 |
523886.3 |
530034.1465 |
|
Value of Portfolio |
1005867 |
946254.1 |
956347.5 |
955702 |
952255.2164 |
In 'portfolio C' we invest 12.5% in FDR @ 10% and 12.5% in equity securities and hold these securities till October. We observed that the value of this portfolio slightly decreased.
Portfolio D
|
July | |||||
|
Company |
Amount to be invested |
Share Price (Beginning) |
Share Purchase |
Purchase price |
MV at the end of month |
|
ACI Limited |
100000 |
80.7 |
1239 |
80 |
99132.59 |
|
Beximco Pharmaceuticals |
100000 |
89.3 |
1120 |
70.8 |
79283.31 |
|
Bangla Process |
100000 |
130 |
769 |
135 |
103846.15 |
|
Imam Button |
100000 |
68.5 |
1460 |
54.75 |
79927.01 |
|
Square Pharmaceuticals |
100000 |
3679.5 |
27 |
3680 |
100013.59 |
|
Total Value of equity investment |
462202.65 | ||||
|
Investment in FDR |
511803.84 | ||||
|
Value of Portfolio |
974006.50 | ||||
|
August | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Purchase Price |
MV at the end of month |
|
Kohinoor Chemicals |
92441 |
625 |
148 |
644 |
95250.72 |
|
Beximco Pharmaceuticals |
92441 |
70.8 |
1306 |
76 |
99229.95 |
|
Bangla Process |
92441 |
135 |
685 |
140 |
95864.25 |
|
Imam Button |
92441 |
54.75 |
1688 |
66.25 |
111857.26 |
|
Square Pharmaceuticals |
92441 |
3680 |
25 |
3369 |
84628.30 |
|
Total Value of equity investment |
486830.49 | ||||
|
Investment in FDR |
517809.85 | ||||
|
Value of Portfolio |
1004640.34 | ||||
|
September | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Purchase Price) |
MV at the end of month |
|
Kohinoor Chemicals |
97366 |
644 |
151 |
644 |
97366.10 |
|
Pharma Aids |
97366 |
294 |
331 |
410 |
135782.65 |
|
Bangla Process |
97366 |
140 |
695 |
140 |
97366.10 |
|
Imam Button |
97366 |
66.25 |
1470 |
64 |
94059.32 |
|
Square Pharmaceuticals |
97366 |
3369 |
29 |
3225 |
93204.41 |
|
Total Value of equity investment |
517778.59 | ||||
|
Investment in FDR |
523886.35 | ||||
|
Value of Portfolio |
1041664.93 | ||||
|
October | |||||
|
Company |
Amount to be invested |
Share Price |
Share Purchase |
Purchase Price |
MV at the end of month |
|
Kohinoor Chemicals |
103556 |
644 |
161 |
665 |
106932.53 |
|
Pharma Aids |
103556 |
410 |
253 |
463.25 |
117005.33 |
|
Bangla Process |
103556 |
140 |
740 |
145 |
107254.14 |
|
Imam Button |
103556 |
64 |
1618 |
55 |
88993.19 |
|
Glaxo SmithKline |
103556 |
170.2 |
608 |
178.4 |
108544.89 |
|
Total Value of equity investment |
528730.09 | ||||
|
Investment in EDR |
530034.15 | ||||
|
Value of Portfolio |
1058764.23 | ||||
In 'portfolio D' we invest 12.5% in FDR @ 10% and 12.5% in equity securities and invest equal amount in each company and follow the strategy of buy and sell. We sell the securities that had decreasing price trend and buy securities that had increasing price trend. We saw that portfolio value increased from its initial investment.
Conclusion
From the different portfolios, we can see that the portfolio B and portfolio D gives us better return than others. In fact portfolio A and portfolio C gives us negative return that means values of these portfolios are less than initial investment.
Value of Total Portfolio
= 918900.55 + 1057460.17 + 952255 + 1058764.23
= 4037379.95
Among the portfolio B and portfolio D, portfolio D gives the maximum return and the total value of the portfolio is more then that we invested.
References
- Investment Analysis And Portfolio Management, Frank K. Reilly, Keith C. Brown
- Managing Equity Risk: Strategies, Stock Index Future, And Portfolio Insurance
- Fundamental of Investment, Charles P. Jones, Frank k. Reilly, Keith C. Brown
- DSE Monthly Review (June, July, August, September, October)
- Annual Reports of Selected Companies
- Websites:
www.dsebd.org (Dhaka Stock Exchange)
www.secbd.org (Securities and Exchange Commission)
www.investopedia.com
Spread The Word
Article Series
-
Portfolio Construction And Management (Last Part)
